Abstract
Introduction Type 2 diabetes mellitus represents a significant chronic health concern, with rural populations being particularly vulnerable due to geographic and socio-economic barriers to healthcare access. To date, few studies have focused on the medical accessibility of rural diabetic patients in Taiwan. This study aims to explore the association between the proximity to healthcare facilities and glycohemoglobin levels in the rural Taiwanese population.
Methods We conducted a retrospective cross-sectional study in rural districts of southern Taiwan. Medical accessibility was calculated from subject’s address to medical units by Google Maps platform. Spearman’s Rank Analysis was performed for the correlation between distance from patient’s address to medical units and glycohemoglobin level. Logistic regression was applied to identify factors associated with glycemic control.
Results In total, 117 patients with type 2 diabetes mellitus were enrolled (mean glycohemoglobin: 8.17±1.92%). Glycohemoglobin level was modestly and positively associated with distance to clinic (Rho: 0.252) and hospital (Rho: 0.241) respectively. In logistic regression analysis, good glycemic control (glycohemoglobin less than 7%) was associated with covariates as not-working status, the address district near downtown, fasting plasma glucose equal to or less than 130 mg/dL, and normal high-density lipoprotein cholesterol level.
Conclusion Our study reveals that accessibility to healthcare facility is modestly correlated with long-term glycemic status in Taiwan rural diabetic population. Besides, we also identified several protective factors associated with chronic glycemic status. These findings may pave the way for improvement of policy and healthcare strategies in rural diabetic care.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by Chang Gung Medical Foundation Institutional Review Board on 14/08/2023. Approval number is 202301135B0.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Main data are within the manuscript. Other precise individual data are available from contact email of corresponding author.
